This outcome is not dissimilar from the results of Oldenburg [38], who demonstrated an ABR of 0.5 with FVIII prophylaxis in a highly adherent cohort of people with hemophilia A, but these individuals still had evidence of long-term joint damage despite this low rate of joint bleeding. This evidence concerns the gene F8 and hemophilia A.